HK1039275A1 - 含有二甲聚硅氧烷的阿昔洛韋組合物 - Google Patents

含有二甲聚硅氧烷的阿昔洛韋組合物

Info

Publication number
HK1039275A1
HK1039275A1 HK02100122.9A HK02100122A HK1039275A1 HK 1039275 A1 HK1039275 A1 HK 1039275A1 HK 02100122 A HK02100122 A HK 02100122A HK 1039275 A1 HK1039275 A1 HK 1039275A1
Authority
HK
Hong Kong
Prior art keywords
aciclovir
compositions containing
containing dimethicone
dimethicone
compositions
Prior art date
Application number
HK02100122.9A
Other languages
English (en)
Inventor
Singh Cheema Parbinder
Gower David
David Mounter Andrew
Giles Sabey Timothy
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10845017&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HK1039275(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of HK1039275A1 publication Critical patent/HK1039275A1/zh

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52Purines, e.g. adenine
    • A61K31/522Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/20Antivirals for DNA viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/20Antivirals for DNA viruses
    • A61P31/22Antivirals for DNA viruses for herpes viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
HK02100122.9A 1998-12-23 2002-01-08 含有二甲聚硅氧烷的阿昔洛韋組合物 HK1039275A1 (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9828620.6A GB9828620D0 (en) 1998-12-23 1998-12-23 Medicaments
PCT/EP1999/010155 WO2000038695A2 (en) 1998-12-23 1999-12-21 Aciclovir compositions containing dimethicone

Publications (1)

Publication Number Publication Date
HK1039275A1 true HK1039275A1 (zh) 2002-04-19

Family

ID=10845017

Family Applications (2)

Application Number Title Priority Date Filing Date
HK02100122.9A HK1039275A1 (zh) 1998-12-23 2002-01-08 含有二甲聚硅氧烷的阿昔洛韋組合物
HK05100005.8A HK1067548A1 (en) 1998-12-23 2005-01-03 Aciclovir compositions containing dimethicone

Family Applications After (1)

Application Number Title Priority Date Filing Date
HK05100005.8A HK1067548A1 (en) 1998-12-23 2005-01-03 Aciclovir compositions containing dimethicone

Country Status (27)

Country Link
EP (1) EP1140117B1 (zh)
JP (1) JP4145493B2 (zh)
KR (1) KR100707329B1 (zh)
CN (2) CN1191834C (zh)
AR (1) AR021993A1 (zh)
AT (1) ATE236644T1 (zh)
AU (1) AU768989B2 (zh)
BR (1) BR9916524A (zh)
CA (1) CA2356895A1 (zh)
CZ (1) CZ295770B6 (zh)
DE (2) DE29924428U1 (zh)
DK (1) DK1140117T3 (zh)
ES (1) ES2196910T3 (zh)
GB (2) GB9828620D0 (zh)
HK (2) HK1039275A1 (zh)
HU (1) HU230542B1 (zh)
IL (2) IL143833A0 (zh)
NO (1) NO322090B1 (zh)
NZ (1) NZ512457A (zh)
PE (1) PE20001351A1 (zh)
PL (1) PL196629B1 (zh)
PT (1) PT1140117E (zh)
SI (1) SI1140117T1 (zh)
TR (1) TR200102482T2 (zh)
TW (1) TW585768B (zh)
WO (1) WO2000038695A2 (zh)
ZA (1) ZA200105071B (zh)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2005824A1 (de) 2007-06-21 2008-12-24 Bayer CropScience AG Wirkstoffsuspensionen in Glycerin
BRPI0914454A2 (pt) * 2008-10-21 2015-10-27 Novodermix Internat Ltd "composição para o tratamento do tecido epitelial"
US20130324502A1 (en) * 2011-02-10 2013-12-05 Moberg Pharma Ab Novel formulations for dermal, transdermal and mucosal use 1
WO2015082172A1 (en) * 2013-12-03 2015-06-11 Zzip Ag Polydimethylsiloxane for the treatment of viral infections

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2080106B (en) * 1980-07-18 1984-03-07 Weelcome Foundation Ltd Acyclovin preparations
JPH02304032A (ja) * 1989-04-24 1990-12-17 Syntex Usa Inc 非イオン界面活性剤含有局所抗ウイルス医薬組成物
GB9114939D0 (en) * 1991-07-11 1991-08-28 Smithkline Beecham Plc Pharmaceutical formulation
FR2728167A1 (fr) * 1994-12-15 1996-06-21 Cird Galderma Composition cosmetique ou dermatologique sous forme d'une emulsion eau dans huile a teneur elevee en hydroxyacides
FR2737118B1 (fr) * 1995-07-28 1997-09-05 Oreal Composition dermatologique ou pharmaceutique, procede de preparation et utilisation

Also Published As

Publication number Publication date
NO20013103D0 (no) 2001-06-21
PL196629B1 (pl) 2008-01-31
NO322090B1 (no) 2006-08-14
HUP0104594A2 (en) 2002-06-29
CA2356895A1 (en) 2000-07-06
HK1067548A1 (en) 2005-04-15
IL143833A (en) 2006-12-31
JP2002542149A (ja) 2002-12-10
ATE236644T1 (de) 2003-04-15
TR200102482T2 (tr) 2003-03-21
WO2000038695A3 (en) 2000-10-26
TW585768B (en) 2004-05-01
CZ295770B6 (cs) 2005-11-16
BR9916524A (pt) 2001-10-02
CN1191834C (zh) 2005-03-09
CN1334737A (zh) 2002-02-06
PE20001351A1 (es) 2000-12-14
KR100707329B1 (ko) 2007-04-13
PL349505A1 (en) 2002-07-29
NO20013103L (no) 2001-08-20
PT1140117E (pt) 2003-08-29
IL143833A0 (en) 2002-04-21
CN100415237C (zh) 2008-09-03
HUP0104594A3 (en) 2002-12-28
EP1140117B1 (en) 2003-04-09
KR20010099932A (ko) 2001-11-09
DK1140117T3 (da) 2003-07-21
GB0117795D0 (en) 2001-09-12
NZ512457A (en) 2003-10-31
DE69906796D1 (de) 2003-05-15
AU768989B2 (en) 2004-01-15
AU2099700A (en) 2000-07-31
WO2000038695A2 (en) 2000-07-06
GB2362105B (en) 2003-06-18
GB2362105A (en) 2001-11-14
SI1140117T1 (en) 2003-12-31
JP4145493B2 (ja) 2008-09-03
CZ20012332A3 (cs) 2001-12-12
DE69906796T2 (de) 2004-01-29
GB9828620D0 (en) 1999-02-17
ES2196910T3 (es) 2003-12-16
CN1539421A (zh) 2004-10-27
DE29924428U1 (de) 2003-08-28
HU230542B1 (hu) 2016-11-28
ZA200105071B (en) 2002-09-20
AR021993A1 (es) 2002-09-04
EP1140117A2 (en) 2001-10-10

Similar Documents

Publication Publication Date Title
PL341372A1 (en) Cellecoxibe containing compositions
GB9804720D0 (en) Shampoo compositions
GB9808310D0 (en) Shampoo compositions
PL347266A1 (en) Antiperspirant compositions
GB9804725D0 (en) Shampoo compositions
GB9726969D0 (en) Mousse-forming shampoo compositions
HU9901606D0 (en) Pharmaceutical compositions
HUP0103507A3 (en) Pharmaceutical compositions comprising 2-quinolones
GB9827996D0 (en) Pharmaceutical Compositions
PL347941A1 (en) Shampoo compositions
PL343627A1 (en) Medicinal compositions
GB9809213D0 (en) Pharmaceutical compositions
PL334568A1 (en) Paroxetin containing compositions
GB9726970D0 (en) Shampoo compositions
PL338922A1 (en) Oral compositions
IL142534A0 (en) Pharmaceutical compositions containing an antigen-adjuvent
GB9812819D0 (en) Dentifrice compositions
GB2362105B (en) Aciclovir compositions containing dimethicone
IL137403A0 (en) Pharmaceutical compositions
GB9818123D0 (en) Cosmetic compositions
GB9818016D0 (en) Cosmetic compositions
GB9806487D0 (en) Pharmaceutical compositions
HU9803024D0 (en) Oral compositions containing ubidekarenone
PL330972A1 (en) Tetrahydrolypstatin containing compositions
GB9804717D0 (en) Shampoo compositions